IDH MUTATION
Clinical trials for IDH MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH MUTATION trials appear
Sign up with your email to follow new studies for IDH MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bile duct cancer: targeted pill may prevent return
Disease control Recruiting nowThis study tests whether a daily pill called ivosidenib can help keep bile duct cancer from returning after surgery and chemotherapy. It is for people with a specific gene change (IDH1 mutation). About 40 adults will take the drug for one year, and researchers will track how many…
Matched conditions: IDH MUTATION
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
Brain tumor combo shows promise in early trial
Disease control Recruiting nowThis study tests a combination of two drugs—ATRA and retifanlimab—in people with a specific type of brain tumor (IDH-mutant glioma) that has returned after prior treatment. The goal is to see if this combo can shrink tumors or slow their growth by boosting the body's immune respo…
Matched conditions: IDH MUTATION
Phase: PHASE2 • Sponsor: Stephen Bagley, MD, MSCE • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New brain tumor drug put to the test in tiny trial
Knowledge-focused Recruiting nowThis early study tests an oral drug called DSP-0390 in 20 adults with IDH-mutant gliomas (a type of brain tumor) who are scheduled for surgery. Participants take the drug for about two weeks before their tumor is removed, allowing researchers to measure how much drug reaches the …
Matched conditions: IDH MUTATION
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC